Advisory Services Network LLC Acquires New Position in Cabot Co. (NYSE:CBT)

Advisory Services Network LLC bought a new position in Cabot Co. (NYSE:CBT) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 6,846 shares of the specialty chemicals company’s stock, valued at approximately $625,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CBT. Orion Portfolio Solutions LLC bought a new stake in shares of Cabot during the 3rd quarter valued at $609,000. MML Investors Services LLC increased its stake in Cabot by 6.5% in the 3rd quarter. MML Investors Services LLC now owns 6,358 shares of the specialty chemicals company’s stock worth $711,000 after buying an additional 389 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in Cabot by 170.2% during the third quarter. Public Employees Retirement System of Ohio now owns 2,351 shares of the specialty chemicals company’s stock valued at $263,000 after acquiring an additional 1,481 shares during the period. Barclays PLC lifted its position in shares of Cabot by 103.9% in the third quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company’s stock valued at $12,699,000 after acquiring an additional 57,907 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Cabot by 1.8% in the third quarter. Geode Capital Management LLC now owns 1,283,686 shares of the specialty chemicals company’s stock worth $143,504,000 after acquiring an additional 22,719 shares during the period. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Cabot stock opened at $78.41 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. Cabot Co. has a twelve month low of $73.63 and a twelve month high of $117.46. The company’s 50-day moving average price is $83.17 and its 200-day moving average price is $95.47. The company has a market cap of $4.25 billion, a PE ratio of 10.41, a price-to-earnings-growth ratio of 0.74 and a beta of 1.04.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. On average, equities research analysts forecast that Cabot Co. will post 7.57 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CBT. Mizuho decreased their target price on Cabot from $122.00 to $110.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 7th. UBS Group lowered their target price on shares of Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a report on Monday, April 7th. StockNews.com cut shares of Cabot from a “buy” rating to a “hold” rating in a research note on Wednesday, April 9th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $93.25.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.